BARBANTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 11.173
AS - Asia 10.408
EU - Europa 8.361
SA - Sud America 1.327
AF - Africa 82
OC - Oceania 11
Totale 31.362
Nazione #
US - Stati Uniti d'America 11.047
HK - Hong Kong 7.854
IE - Irlanda 5.956
SG - Singapore 1.758
BR - Brasile 1.146
GB - Regno Unito 913
CH - Svizzera 406
FI - Finlandia 323
VN - Vietnam 233
IT - Italia 231
DE - Germania 207
TR - Turchia 132
CN - Cina 104
AR - Argentina 69
CA - Canada 63
FR - Francia 56
BD - Bangladesh 55
IN - India 54
MX - Messico 44
EE - Estonia 40
EC - Ecuador 37
NL - Olanda 37
CZ - Repubblica Ceca 36
RU - Federazione Russa 29
ZA - Sudafrica 29
PL - Polonia 28
KR - Corea 25
UZ - Uzbekistan 23
ID - Indonesia 22
IQ - Iraq 22
CO - Colombia 20
JP - Giappone 20
PK - Pakistan 18
SE - Svezia 18
AT - Austria 16
ES - Italia 15
PY - Paraguay 13
UA - Ucraina 13
UY - Uruguay 13
MA - Marocco 12
CL - Cile 11
EG - Egitto 11
IR - Iran 11
KE - Kenya 10
VE - Venezuela 10
AU - Australia 9
IL - Israele 9
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
PE - Perù 7
JO - Giordania 6
LT - Lituania 6
SA - Arabia Saudita 6
BG - Bulgaria 5
NP - Nepal 5
PH - Filippine 5
TN - Tunisia 5
AZ - Azerbaigian 4
BE - Belgio 4
ET - Etiopia 4
KG - Kirghizistan 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
JM - Giamaica 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AL - Albania 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
LB - Libano 2
LY - Libia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
Totale 31.354
Città #
Hong Kong 7.853
Dallas 6.292
Dublin 5.918
Ashburn 865
London 833
Boardman 807
Singapore 768
Santa Clara 434
Zurich 406
Helsinki 312
The Dalles 274
Washington 197
Istanbul 110
Los Angeles 106
São Paulo 97
Ho Chi Minh City 85
Assago 76
Munich 72
Hanoi 51
San Francisco 42
Chicago 41
New York 38
Rio de Janeiro 36
Belo Horizonte 34
Montreal 28
Milan 27
Brooklyn 26
Council Bluffs 26
Frankfurt am Main 26
Seattle 26
Seoul 25
Warsaw 23
Brasília 22
Brno 21
Tashkent 20
Amsterdam 18
Stockholm 18
Johannesburg 17
Porto Alegre 17
Salvador 17
Atlanta 16
Boston 16
Mexico City 16
Curitiba 15
Guayaquil 15
Catania 14
Olomouc 14
Shanghai 14
Tokyo 14
Chennai 12
Falkenstein 12
Montevideo 12
Quito 12
Duque de Caxias 11
Cipolletti 10
Da Nang 10
Dhaka 10
Goiânia 10
Guarulhos 10
Haiphong 10
Rome 10
Bexley 9
Campinas 9
Clifton 9
Düsseldorf 9
Manchester 9
Nairobi 9
Phoenix 9
Piscataway 9
Turku 9
Buenos Aires 8
Fortaleza 8
Guangzhou 8
Hải Dương 8
Tanta 8
Tappahannock 8
Columbus 7
Denver 7
Genoa 7
Joinville 7
Karachi 7
Osasco 7
Ottawa 7
Ribeirão Preto 7
Thái Bình 7
Toronto 7
Amman 6
Ankara 6
Canoas 6
City of London 6
Maceió 6
Marília 6
Mumbai 6
Recife 6
San Jose 6
Sumaré 6
São José dos Campos 6
Turin 6
Aracaju 5
Araraquara 5
Totale 26.648
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.445
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.164
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 958
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 954
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 711
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 640
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 554
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 532
Predicting neocommissural orientation during TAVI workup 496
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 487
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 426
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 374
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 371
Le nuove frontiere della cardiologia interventistica strutturale 350
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 136
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 128
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 122
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 121
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 118
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 118
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 118
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 111
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 111
Transcatheter mitral valve implantation: CardiAQ 110
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 110
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 110
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 101
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 99
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 97
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 97
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 97
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 96
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 96
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 95
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 94
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 94
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 93
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 93
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 93
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 92
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 89
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 88
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 87
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 86
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 85
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 85
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 84
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 82
Managing complications after transcatheter aortic valve implantation 81
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 81
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 80
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 80
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 80
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 79
Early detection of transcatheter heart valve dysfunction 79
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 79
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 78
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 76
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 76
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 76
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 76
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 75
The Helio transcatheter aortic dock for patients with aortic regurgitation 75
Cerebral embolization during transcatheter aortic valve implantation 75
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 75
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 75
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 74
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 74
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 73
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 73
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 73
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 73
Management of severe stenosis controversies and promises 73
Bioprosthetic valves for transcatheter aortic valve replacement 72
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 72
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 72
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 72
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 71
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 71
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 70
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 70
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 69
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 69
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 69
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 69
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 69
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 69
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 69
Transcatheter mitral valve repair: a brief review 68
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 68
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 68
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 68
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 68
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 68
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 68
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 68
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 67
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 67
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 67
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 67
Totale 17.672
Categoria #
all - tutte 140.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/20268.579 870 3.391 3.663 655 0 0 0 0 0 0 0 0
Totale 31.804